Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 2.185
Filtrer
1.
Drug Deliv ; 31(1): 2372269, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-38956885

RÉSUMÉ

Acne is a common chronic inflammatory disorder of the sebaceous gland in the hair follicle. Commonly used external medications cause skin irritation, and the transdermal capacity is weak, making it difficult to penetrate the cuticle skin barrier. Hair follicles can aid in the breakdown of this barrier. As nanomaterials progress, polymer-based nanocarriers are routinely used for hair follicle drug delivery to treat acne and other skin issues. Based on the physiological and anatomical characteristics of hair follicles, this paper discusses factors affecting hair follicle delivery by polymer nanocarriers, summarizes the common combination technology to improve the targeting of hair follicles by carriers, and finally reviews the most recent research progress of different polymer nanodrug-delivery systems for the treatment of acne by targeting hair follicles.


Sujet(s)
Acné juvénile , Vecteurs de médicaments , Follicule pileux , Polymères , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/métabolisme , Acné juvénile/traitement médicamenteux , Humains , Polymères/composition chimique , Vecteurs de médicaments/composition chimique , Systèmes de délivrance de médicaments/méthodes , Nanoparticules , Administration par voie cutanée , Animaux , Système d'administration de médicaments à base de nanoparticules/composition chimique
2.
Cells ; 13(12)2024 Jun 10.
Article de Anglais | MEDLINE | ID: mdl-38920642

RÉSUMÉ

The advent of induced pluripotent stem cell (iPSC) technology has brought about transformative advancements in regenerative medicine, offering novel avenues for disease modeling, drug testing, and cell-based therapies. Patient-specific iPSC-based treatments hold the promise of mitigating immune rejection risks. However, the intricacies and costs of producing autologous therapies present commercial challenges. The hair follicle is a multi-germ layered versatile cell source that can be harvested at any age. It is a rich source of keratinocytes, fibroblasts, multipotent stromal cells, and the newly defined Hair Follicle-Associated Pluripotent Stem Cells (HAP). It can also be obtained non-invasively and transported via regular mail channels, making it the ideal starting material for an autologous biobank. In this study, cryopreserved hair follicle-derived iPSC lines (HF-iPS) were established through integration-free vectors, encompassing a diverse cohort. These genetically stable lines exhibited robust expression of pluripotency markers, and showcased tri-lineage differentiation potential. The HF-iPSCs effectively differentiated into double-positive cKIT+/CXCR4+ definitive endoderm cells and NKX6.1+/PDX1+ pancreatic progenitor cells, affirming their pluripotent attributes. We anticipate that the use of plucked hair follicles as an accessible, non-invasive cell source to obtain patient cells, in conjunction with the use of episomal vectors for reprogramming, will improve the future generation of clinically applicable pancreatic progenitor cells for the treatment of Type I Diabetes.


Sujet(s)
Différenciation cellulaire , Follicule pileux , Cellules souches pluripotentes induites , Cellules souches pluripotentes induites/cytologie , Cellules souches pluripotentes induites/métabolisme , Humains , Follicule pileux/cytologie , Follicule pileux/métabolisme , Pancréas/cytologie , Pancréas/métabolisme , Femelle
3.
Arch Dermatol Res ; 316(6): 330, 2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38837051

RÉSUMÉ

Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are primary cicatricial alopecia that cause a major impact on quality of life due to irreversible hair loss and symptoms as itching, burning and pain. They are characterized by permanent loss of hair follicle stem cells (HFSCs) by pathomechanisms still poorly understood, resulting in poor efficacy of currently available treatments. Caveolae are flask-shaped lipid rafts invaginated within the plasma membrane of multiple cell types. Although their role in the HF physiology and pathophysiology is relatively unknown, we have previously demonstrated that the primary structural component of caveolae (caveolin-1 or Cav1) is upregulated in FFA. Thus, we propose to investigate the expression and localization of caveolae-associated structural proteins (Cav1, Cav2, and Cavin-1) and HFSCs (identified by K15) in both LPP and FFA. We analyzed 4 patients with LPP biopsied in affected and non-affected (NA) scalp, 4 patients with FFA biopsied in affected scalp and 4 healthy controls. Affected scalp of LPP and FFA demonstrated increased levels of Cav1 and Cavin-1 compared with HC and LPP-NA. Moreover, Cav1, Cav2 and Cavin1 all exhibit high colocalization with K15 and their expression appears to be negatively correlated, supporting the hypothesis that these proteins are important players in LPP/FFA and may serve as therapeutic targets in future treatments.


Sujet(s)
Alopécie , Cavéoles , Cavéoline-1 , Follicule pileux , Lichen plan , Régulation positive , Humains , Alopécie/anatomopathologie , Alopécie/métabolisme , Follicule pileux/anatomopathologie , Follicule pileux/métabolisme , Lichen plan/métabolisme , Lichen plan/anatomopathologie , Adulte d'âge moyen , Femelle , Cavéoline-1/métabolisme , Mâle , Cavéoles/métabolisme , Cuir chevelu/anatomopathologie , Adulte , Kératine-15/métabolisme , Sujet âgé , Biopsie , Fibrose , Cellules souches/métabolisme , Cellules souches/anatomopathologie , Protéines de liaison à l'ARN/métabolisme
4.
J Microorg Control ; 29(2): 63-73, 2024.
Article de Anglais | MEDLINE | ID: mdl-38880618

RÉSUMÉ

Cutibacterium acnes is an opportunistic pathogen recognized as a contributing factor to acne vulgaris. The accumulation of keratin and sebum plugs in hair follicles facilitates C. acnes proliferation, leading to inflammatory acne. Although numerous antimicrobial cosmetic products for acne-prone skin are available, their efficacy is commonly evaluated against planktonic cells of C. acnes. Limited research has assessed the antimicrobial effects on microorganisms within keratin and sebum plugs. This study investigates whether an antibacterial toner can penetrate keratin and sebum plugs, exhibiting bactericidal effects against C. acnes. Scanning electron microscopy and next-generation sequencing analysis of the keratin and sebum plug suggest that C. acnes proliferate within the plug, predominantly in a biofilm-like morphology. To clarify the potential bactericidal effect of the antibacterial toner against C. acnes inside keratin and sebum plugs, we immersed the plugs in the toner, stained them with LIVE/DEAD BacLight Bacterial Viability Kit to visualize microorganism viability, and observed them using confocal laser scanning microscopy. Results indicate that most microorganisms in the plugs were killed by the antibacterial toner. To quantitatively evaluate the bactericidal efficacy of the toner against C. acnes within keratin and sebum, we immersed an artificial plug with inoculated C. acnes type strain and an isolate collected from acne-prone skin into the toner and obtained viable cell counts. The number of the type strain and the isolate inside the artificial plug decreased by over 2.2 log and 1.2 log, respectively, showing that the antibacterial toner exhibits bactericidal effects against C. acnes via keratin and sebum plug penetration.


Sujet(s)
Acné juvénile , Antibactériens , Kératines , Sébum , Sébum/métabolisme , Antibactériens/pharmacologie , Humains , Kératines/métabolisme , Acné juvénile/microbiologie , Acné juvénile/traitement médicamenteux , Biofilms/effets des médicaments et des substances chimiques , Viabilité microbienne/effets des médicaments et des substances chimiques , Propionibacteriaceae/effets des médicaments et des substances chimiques , Propionibacteriaceae/métabolisme , Propionibacteriaceae/génétique , Propionibacterium acnes/effets des médicaments et des substances chimiques , Propionibacterium acnes/métabolisme , Follicule pileux/microbiologie , Follicule pileux/métabolisme , Microscopie électronique à balayage
5.
Exp Dermatol ; 33(6): e15117, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38884504

RÉSUMÉ

Alopecia areata (AA) is an autoimmune inflammatory disease characterized by non-scarring hair loss due to an immune response that targets hair follicles. The current treatment approach for AA involves the use of immunosuppressants and immunomodulators to reduce cytokine levels around affected hair follicles. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as potential anti-inflammatory agents with diverse beneficial effects in various medical conditions. This study investigates the role of beta-hydroxybutyrate (BHB), a ketone body produced during SGLT2 inhibition, in the pathogenesis of AA. Serum BHB levels were found to be significantly elevated in patients with AA compared with healthy controls, with higher levels correlating with severity of hair loss. BHB treatment increased inflammatory cytokine production in outer root sheath (ORS) cells, mimicking the inflammatory conditions seen in AA. The results suggest that elevated BHB levels may exacerbate the inflammatory immune response in AA patients and may be associated with chronic hair loss and resistance to treatment. Serum BHB levels may serve as a potential marker of poor prognosis in patients with severe AA. Further research is needed to elucidate the precise role of BHB in the pathogenesis of AA and its implications for disease management.


Sujet(s)
Acide 3-hydroxy-butyrique , Pelade , Inflammation , Pelade/traitement médicamenteux , Pelade/sang , Pelade/immunologie , Humains , Acide 3-hydroxy-butyrique/sang , Adulte , Femelle , Mâle , Études cas-témoins , Cytokines/métabolisme , Cytokines/sang , Follicule pileux/métabolisme , Jeune adulte , Adulte d'âge moyen
6.
Arch Dermatol Res ; 316(7): 360, 2024 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-38850442

RÉSUMÉ

While many gene expression studies have focused on male pattern baldness (MPB), few studies have investigated the genetic differences between bald and non-bald hair follicles in female pattern hair loss (FPHL). This study aimed to identify molecular biomarkers associated with FPHL through genetic analysis of paired bald and non-bald hair follicles from 18 FPHL patients, using next-generation sequencing (NGS) techniques. RNA transcriptome analysis was performed to identify differentially expressed genes (DEGs) between bald and non-bald hair follicles in FPHL. The DEGs were validated using real-time PCR, and protein expression was confirmed through immunohistochemistry and western blot analysis. Our findings suggest that HOXB13, SFRP2, PTGDS, CXCR3, SFRP4, SOD3, and DCN are significantly upregulated in bald hair follicles compared to non-bald hair follicles in FPHL. SFRP2 and PTGDS were found to be consistently highly expressed in bald hair follicles in all 18 samples. Additionally, elevated protein levels of SFRP2 and PTGDS were confirmed through western blot and immunohistochemical analysis. Our study identified SFRP2 and PTGDS as potential biomarkers for FPHL and suggests that they may play a role in inducing hair loss in this condition. These findings provide a foundation for further research on the pathogenesis of FPHL and potential therapeutic targets.


Sujet(s)
Alopécie , Asiatiques , Analyse de profil d'expression de gènes , Follicule pileux , Adulte , Femelle , Humains , Adulte d'âge moyen , Jeune adulte , Alopécie/génétique , Alopécie/anatomopathologie , Asiatiques/génétique , Follicule pileux/métabolisme , Follicule pileux/anatomopathologie , Séquençage nucléotidique à haut débit , Protéines membranaires/génétique , Protéines membranaires/métabolisme , Protéines proto-oncogènes , Cuir chevelu/anatomopathologie , Transcriptome
7.
BMC Genomics ; 25(1): 574, 2024 Jun 07.
Article de Anglais | MEDLINE | ID: mdl-38849762

RÉSUMÉ

BACKGROUND: The Qinghai Tibetan sheep, a local breed renowned for its long hair, has experienced significant deterioration in wool characteristics due to the absence of systematic breeding practices. Therefore, it is imperative to investigate the molecular mechanisms underlying follicle development in order to genetically enhance wool-related traits and safeguard the sustainable utilization of valuable germplasm resources. However, our understanding of the regulatory roles played by coding and non-coding RNAs in hair follicle development remains largely elusive. RESULTS: A total of 20,874 mRNAs, 25,831 circRNAs, 4087 lncRNAs, and 794 miRNAs were annotated. Among them, we identified 58 DE lncRNAs, 325 DE circRNAs, 924 DE mRNAs, and 228 DE miRNAs during the development of medullary primary hair follicle development. GO and KEGG functional enrichment analyses revealed that the JAK-STAT, TGF-ß, Hedgehog, PPAR, cGMP-PKG signaling pathway play crucial roles in regulating fibroblast and epithelial development during skin and hair follicle induction. Furthermore, the interactive network analysis additionally identified several crucial mRNA, circRNA, and lncRNA molecules associated with the process of primary hair follicle development. Ultimately, by investigating DEmir's role in the ceRNA regulatory network mechanism, we identified 113 circRNA-miRNA pairs and 14 miRNA-mRNA pairs, including IGF2BP1-miR-23-x-novel-circ-01998-MSTRG.7111.3, DPT-miR-370-y-novel-circ-005802-MSTRG.14857.1 and TSPEAR-oar-miR-370-3p-novel-circ-005802- MSTRG.10527.1. CONCLUSIONS: Our study offers novel insights into the distinct expression patterns of various transcription types during hair follicle morphogenesis, establishing a solid foundation for unraveling the molecular mechanisms that drive hair development and providing a scientific basis for selectively breeding desirable wool-related traits in this specific breed.


Sujet(s)
Réseaux de régulation génique , Follicule pileux , microARN , ARN circulaire , ARN long non codant , ARN messager , Animaux , Follicule pileux/métabolisme , Follicule pileux/croissance et développement , ARN circulaire/génétique , ARN circulaire/métabolisme , microARN/génétique , microARN/métabolisme , Ovis/génétique , ARN messager/génétique , ARN messager/métabolisme , ARN long non codant/génétique , ARN long non codant/métabolisme , Analyse de profil d'expression de gènes , Peau/métabolisme , Transcriptome , Foetus/métabolisme
8.
PLoS One ; 19(6): e0303742, 2024.
Article de Anglais | MEDLINE | ID: mdl-38900734

RÉSUMÉ

Unravelling how energy metabolism and stress responses are regulated in human scalp hair follicles could reveal novel insights into the controls of hair growth and provide new targets to manage hair loss disorders. The Mitochondrial Pyruvate Carrier (MPC) imports pyruvate, produced via glycolysis, into the mitochondria, fuelling the TCA cycle. Previous work has shown that MPC inhibition promotes lactate generation, which activates murine epithelial hair follicle stem cells (eHFSCs). However, by pharmacologically targeting the MPC in short-term human hair follicle ex vivo organ culture experiments using UK-5099, we induced metabolic stress-responsive proliferative arrest throughout the human hair follicle epithelium, including within Keratin 15+ eHFSCs. Through transcriptomics, MPC inhibition was shown to promote a gene expression signature indicative of disrupted FGF, IGF, TGFß and WNT signalling, mitochondrial dysfunction, and activation of the integrated stress response (ISR), which can arrest cell cycle progression. The ISR, mediated by the transcription factor ATF4, is activated by stressors including amino acid deprivation and ER stress, consistent with MPC inhibition within our model. Using RNAScope, we confirmed the upregulation of both ATF4 and the highly upregulated ATF4-target gene ADM2 on human hair follicle tissue sections in situ. Moreover, treatment with the ISR inhibitor ISRIB attenuated both the upregulation of ADM2 and the proliferative block imposed via MPC inhibition. Together, this work reveals how the human hair follicle, as a complex and metabolically active human tissue system, can dynamically adapt to metabolic stress.


Sujet(s)
Follicule pileux , Humains , Follicule pileux/métabolisme , Facteur de transcription ATF-4/métabolisme , Facteur de transcription ATF-4/génétique , Stress physiologique , Prolifération cellulaire , Mitochondries/métabolisme
9.
Eur J Pharm Biopharm ; 200: 114346, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38823541

RÉSUMÉ

Tazarotene is a widely prescribed topical retinoid for acne vulgaris and plaque psoriasis and is associated with skin irritation, dryness, flaking, and photosensitivity. In vitro permeation of tazarotene was studied across the dermatomed human and full-thickness porcine skin. The conversion of tazarotene to the active form tazarotenic acid was studied in various skin models. Tazarotene-loaded PLGA nanoparticles were prepared using the nanoprecipitation technique to target skin and hair follicles effectively. The effect of formulation and processing variables on nanoparticle properties, such as particle size and drug loading, was investigated. The optimized nanoparticle batches with particle size <500 µm were characterized further for FT-IR analysis, which indicated no interactions between tazarotene and PLGA. Scanning electron microscopy analysis showed uniform, spherical, and non-agglomerated nanoparticles. In vitro release study using a dialysis membrane indicated a sustained release of 40-70 % for different batches over 36 h, following a diffusion-based release mechanism based on the Higuchi model. In vitro permeation testing (IVPT) in full-thickness porcine skin showed significantly enhanced follicular and skin delivery from nanoparticles compared to solution. The presence of tazarotenic acid in the skin from tazarotene nanoparticles indicated the effectiveness of nanoparticle formulations in retaining bioconversion ability and targeting follicular delivery.


Sujet(s)
Nanoparticules , Acides nicotiniques , Taille de particule , Copolymère d'acide poly(lactique-co-glycolique) , Absorption cutanée , Peau , Acides nicotiniques/administration et posologie , Acides nicotiniques/composition chimique , Acides nicotiniques/pharmacocinétique , Copolymère d'acide poly(lactique-co-glycolique)/composition chimique , Animaux , Suidae , Nanoparticules/composition chimique , Humains , Absorption cutanée/effets des médicaments et des substances chimiques , Peau/métabolisme , Peau/effets des médicaments et des substances chimiques , Produits dermatologiques/administration et posologie , Produits dermatologiques/pharmacocinétique , Produits dermatologiques/composition chimique , Vecteurs de médicaments/composition chimique , Follicule pileux/métabolisme , Follicule pileux/effets des médicaments et des substances chimiques , Libération de médicament , Administration par voie cutanée , Chimie pharmaceutique/méthodes , Systèmes de délivrance de médicaments/méthodes , Acné juvénile/traitement médicamenteux , Préparation de médicament/méthodes , Maladies de la peau/traitement médicamenteux
10.
J Cell Mol Med ; 28(12): e18486, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38923380

RÉSUMÉ

Hair follicle development and hair growth are regulated by multiple factors and multiple signalling pathways. The hair follicle, as an important skin appendage, is the basis for hair growth, and it has the functions of safeguarding the body, perceiving the environment and regulating body temperature. Hair growth undergoes a regular hair cycle, including anagen, catagen and telogen. A small amount of physiological shedding of hair occurs under normal conditions, always in a dynamic equilibrium. Hair loss occurs when the skin or hair follicles are stimulated by oxidative stress, inflammation or hormonal disorders that disrupt the homeostasis of the hair follicles. Numerous researches have indicated that oxidative stress is an important factor causing hair loss. Here, we summarize the signalling pathways and intervention mechanisms by which oxidative stress affects hair follicle development and hair growth, discuss existing treatments for hair loss via the antioxidant pathway and provide our own insights. In addition, we collate antioxidant natural products promoting hair growth in recent years and discuss the limitations and perspectives of current hair loss prevention and treatment.


Sujet(s)
Antioxydants , Follicule pileux , Stress oxydatif , Transduction du signal , Follicule pileux/croissance et développement , Follicule pileux/métabolisme , Follicule pileux/effets des médicaments et des substances chimiques , Humains , Antioxydants/métabolisme , Antioxydants/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Animaux , Poils/croissance et développement , Poils/métabolisme , Poils/effets des médicaments et des substances chimiques , Alopécie/métabolisme , Alopécie/traitement médicamenteux , Produits biologiques/pharmacologie
11.
Int J Mol Sci ; 25(12)2024 Jun 13.
Article de Anglais | MEDLINE | ID: mdl-38928239

RÉSUMÉ

Aging (senescence) is an unavoidable biological process that results in visible manifestations in all cutaneous tissues, including scalp skin and hair follicles. Previously, we evaluated the molecular function of adenosine in promoting alopecia treatment in vitro. To elucidate the differences in the molecular mechanisms between minoxidil (MNX) and adenosine, gene expression changes in dermal papilla cells were examined. The androgen receptor (AR) pathway was identified as a candidate target of adenosine for hair growth, and the anti-androgenic activity of adenosine was examined in vitro. In addition, ex vivo examination of human hair follicle organ cultures revealed that adenosine potently elongated the anagen stage. According to the severity of alopecia, the ratio of the two peaks (terminal hair area/vellus hair area) decreased continuously. We further investigated the adenosine hair growth promoting effect in vivo to examine the hair thickness growth effects of topical 5% MNX and the adenosine complex (0.75% adenosine, 1% penthenol, and 2% niacinamide; APN) in vivo. After 4 months of administration, both the MNX and APN group showed significant increases in hair density (MNX + 5.01% (p < 0.01), APN + 6.20% (p < 0.001)) and thickness (MNX + 5.14% (p < 0.001), APN + 10.32% (p < 0.001)). The inhibition of AR signaling via adenosine could have contributed to hair thickness growth. We suggest that the anti-androgenic effect of adenosine, along with the evaluation of hair thickness distribution, could help us to understand hair physiology and to investigate new approaches for drug development.


Sujet(s)
Adénosine , Alopécie , Follicule pileux , Poils , Minoxidil , Récepteurs aux androgènes , Transduction du signal , Alopécie/traitement médicamenteux , Alopécie/métabolisme , Alopécie/anatomopathologie , Humains , Mâle , Récepteurs aux androgènes/métabolisme , Adénosine/métabolisme , Adénosine/pharmacologie , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/métabolisme , Follicule pileux/croissance et développement , Transduction du signal/effets des médicaments et des substances chimiques , Minoxidil/pharmacologie , Femelle , Animaux , Poils/croissance et développement , Poils/effets des médicaments et des substances chimiques , Poils/métabolisme
12.
Cells ; 13(11)2024 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-38891117

RÉSUMÉ

Fibroblast growth factor 5 (FGF5) plays key roles in promoting the transition from the anagen to catagen during the hair follicle cycle. The sheep serves as an excellent model for studying hair growth and is frequently utilized in various research processes related to human skin diseases. We used the CRISPR/Cas9 system to generate four FGF5-edited Dorper sheep and only low levels of FGF5 were detected in the edited sheep. The density of fine wool in GE sheep was markedly increased, and the proportion of fine wool with a diameter of 14.4-20.0 µm was significantly higher. The proliferation signal in the skin of gene-edited (GE) sheep was stronger than in wild-type (WT) sheep. FGF5 editing decreased cortisol concentration in the skin, further activated the activity of antioxidant enzymes such as Glutathione peroxidase (GSH-Px), and regulated the expression of Wnt signaling pathways containing Wnt agonists (Rspondins, Rspos) and antagonists (Notum) in hair regeneration. We suggest that FGF5 not only mediates the activation of antioxidant pathways by cortisol, which constitutes a highly coordinated microenvironment in hair follicle cells, but also influences key signals of the Wnt pathway to regulate secondary hair follicle (SHF) development. Overall, our findings here demonstrate that FGF5 plays a significant role in regulating SHF growth in sheep and potentially serves as a molecular marker of fine wool growth in sheep breeding.


Sujet(s)
Facteur de croissance fibroblastique de type 5 , Glutathione peroxidase , Follicule pileux , Voie de signalisation Wnt , Laine , Animaux , Facteur de croissance fibroblastique de type 5/métabolisme , Facteur de croissance fibroblastique de type 5/génétique , Ovis , Laine/métabolisme , Follicule pileux/métabolisme , Follicule pileux/croissance et développement , Glutathione peroxidase/métabolisme , Glutathione peroxidase/génétique , Édition de gène , Hydrocortisone/métabolisme , Prolifération cellulaire , Systèmes CRISPR-Cas/génétique
13.
Genes (Basel) ; 15(5)2024 05 15.
Article de Anglais | MEDLINE | ID: mdl-38790256

RÉSUMÉ

Much research has been conducted to determine how hair regeneration is regulated, as this could provide therapeutic, cosmetic, and even psychological interventions for hair loss. The current study focused on the hair growth effect and effective utilization of fatty oil obtained from Bryde's whales through a high-throughput DNA microarray approach in conjunction with immunohistochemical observations. The research also examined the mechanisms and factors involved in hair growth. In an experiment using female C57BL/6J mice, the vehicle control group (VC: propylene glycol: ethanol: water), the positive control group (MXD: 3% minoxidil), and the experimental group (WO: 20% whale oil) were topically applied to the dorsal skin of the mouse. The results showed that 3% MXD and 20% WO were more effective than VC in promoting hair growth, especially 20% WO. Furthermore, in hematoxylin and eosin-stained dorsal skin tissue, an increase in the number of hair follicles and subcutaneous tissue thickness was observed with 20% WO. Whole-genome transcriptome analysis also confirmed increases for 20% WO in filaggrin (Flg), a gene related to skin barrier function; fibroblast growth factor 21 (Fgf21), which is involved in hair follicle development; and cysteine-rich secretory protein 1 (Crisp1), a candidate gene for alopecia areata. Furthermore, the results of KEGG pathway analysis indicated that 20% WO may have lower stress and inflammatory responses than 3% MXD. Therefore, WO is expected to be a safe hair growth agent.


Sujet(s)
Poils , Huiles , Animaux , Femelle , Souris , Biologie informatique/méthodes , Protéines filaggrine , Analyse de profil d'expression de gènes/méthodes , Poils/croissance et développement , Poils/effets des médicaments et des substances chimiques , Poils/métabolisme , Follicule pileux/métabolisme , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/croissance et développement , Souris de lignée C57BL , Minoxidil/administration et posologie , Séquençage par oligonucléotides en batterie/méthodes , Peau/métabolisme , Peau/effets des médicaments et des substances chimiques , Baleines , Huiles/administration et posologie
14.
Arch Dermatol Res ; 316(6): 290, 2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38809465

RÉSUMÉ

Enz_MoriL is a naturally occurring substance extracted from the leaves of Morus alba L. through enzymatic conversion. Historically, M. alba L. has been recognized for its potential to promote hair regrowth. However, the precise mechanism by which Enz_MoriL affects human hair follicle dermal papilla cells (hDPCs) remains unclear. The aim of this study was to investigate the molecular basis of Enz_MoriL's effect on hair growth in hDPCs. Interferon-gamma (IFN-γ) was used to examine the effects of Enz_MoriL on hDPCs during the anagen and catagen phases, as well as under conditions mimicking alopecia areata (AA). Enz_MoriL demonstrated the ability to promote cell proliferation in both anagen and catagen stages. It increased the levels of active ß-catenin in the catagen stage induced by IFN-γ, leading to its nuclear translocation. This effect was achieved by increasing the phosphorylation of GSK3ß and decreasing the expression of DKK-1. This stimulation induced proliferation in hDPCs and upregulated the expression of the Wnt family members 3a, 5a, and 7a at the transcript level. Additionally, Enz_MoriL suppressed JAK1 and STAT3 phosphorylation, contrasting with IFN-γ, which induced them in the catagen stage. In conclusion, Enz_MoriL directly induced signals for anagen re-entry into hDPCs by affecting the Wnt/ß-catenin pathway and enhancing the production of growth factors. Furthermore, Enz_MoriL attenuated and reversed the interferon-induced AA-like environment by blocking the JAK-STAT pathway in hDPCs.


Sujet(s)
Pelade , Prolifération cellulaire , Follicule pileux , Interféron gamma , Voie de signalisation Wnt , bêta-Caténine , Humains , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/cytologie , Follicule pileux/métabolisme , Prolifération cellulaire/effets des médicaments et des substances chimiques , Voie de signalisation Wnt/effets des médicaments et des substances chimiques , Interféron gamma/métabolisme , bêta-Caténine/métabolisme , Pelade/métabolisme , Pelade/traitement médicamenteux , Pelade/anatomopathologie , Cellules cultivées , Glycogen synthase kinase 3 beta/métabolisme , Protéines et peptides de signalisation intercellulaire/métabolisme , Janus kinases/métabolisme , Derme/cytologie , Derme/effets des médicaments et des substances chimiques , Phosphorylation/effets des médicaments et des substances chimiques , Facteur de transcription STAT-3/métabolisme , Poils/effets des médicaments et des substances chimiques , Poils/croissance et développement , Protéine Wnt-5a/métabolisme , Janus kinase 1/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Facteurs de transcription STAT/métabolisme
15.
Drug Dev Ind Pharm ; 50(6): 524-536, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38752842

RÉSUMÉ

OBJECTIVES: Melanin is considered the main chromophore for laser hair removal. Due to a lack of laser-absorbing chromophores, removing non-pigmented hair with laser is quite problematic with unsatisfactory outcomes. This problem could be solved by delivering more melanin to the area around the hair follicle and enhancing that area as a target for light absorption. The insolubility of Sepia melanin as an exogenous dye, in most solvents, limits its bioavailability and thus its clinical use. METHODS: In our study, to overcome the solubility problems and increase the bioavailability of melanin for biomedical and cosmetic applications, natural sepia melanin was loaded in different nano-delivery systems (spanlastics and transfersomes) to be delivered to the hair follicles. The different formulations of melanin were prepared and characterized. In vivo skin deposition and histopathological studies were conducted on albino mice. RESULTS: Transmission electron microscopy (TEM) showed the spherical shape of the prepared vesicles with an average particle size of 252 and 262 nm and zeta potential of -22.5 and -35 mV for melanin spanlastics and melanin transfersomes, respectively. Histopathological examination of hair follicles and pilosebaceous glands for the irradiated and non-irradiated albino mice skin was studied post the application of the prepared formulations topically and subcutaneously. Qualitative statistical analysis was conducted and melanin transfersomes and melanin spanlastics showed significant damage to pilosebaceous glands and hair follicles with a p-value of 0.031 and 0.009 respectively. CONCLUSION: Melanin nanovesicles as transfersomes and spanlastics could be considered a promising approach for the removal of non-pigmented hair.


Sujet(s)
Follicule pileux , Épilation , Mélanines , Nanoparticules , Sepia , Animaux , Mélanines/métabolisme , Épilation/méthodes , Souris , Nanoparticules/composition chimique , Follicule pileux/métabolisme , Sepia/composition chimique , Lasers , Taille de particule , Peau/métabolisme , Biodisponibilité
16.
JCI Insight ; 9(13)2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38771644

RÉSUMÉ

Hypotrichosis is a genetic disorder characterized by a diffuse and progressive loss of scalp and/or body hair. Nonetheless, the causative genes for several affected individuals remain elusive, and the underlying mechanisms have yet to be fully elucidated. Here, we discovered a dominant variant in a disintegrin and a metalloproteinase domain 17 (ADAM17) gene caused hypotrichosis with woolly hair. Adam17 (p.D647N) knockin mice mimicked the hair abnormality in patients. ADAM17 (p.D647N) mutation led to hair follicle stem cell (HFSC) exhaustion and caused abnormal hair follicles, ultimately resulting in alopecia. Mechanistic studies revealed that ADAM17 binds directly to E3 ubiquitin ligase tripartite motif-containing protein 47 (TRIM47). ADAM17 variant enhanced the association between ADAM17 and TRIM47, leading to an increase in ubiquitination and subsequent degradation of ADAM17 protein. Furthermore, reduced ADAM17 protein expression affected the Notch signaling pathway, impairing the activation, proliferation, and differentiation of HFSCs during hair follicle regeneration. Overexpression of Notch intracellular domain rescued the reduced proliferation ability caused by Adam17 variant in primary fibroblast cells.


Sujet(s)
Protéine ADAM17 , Alopécie , Follicule pileux , Ubiquitin-protein ligases , Protéine ADAM17/métabolisme , Protéine ADAM17/génétique , Animaux , Alopécie/génétique , Alopécie/métabolisme , Alopécie/anatomopathologie , Souris , Follicule pileux/métabolisme , Follicule pileux/anatomopathologie , Humains , Ubiquitin-protein ligases/génétique , Ubiquitin-protein ligases/métabolisme , Ubiquitination , Mâle , Transduction du signal/génétique , Protéines à motif tripartite/métabolisme , Protéines à motif tripartite/génétique , Femelle , Mutation , Techniques de knock-in de gènes , Prolifération cellulaire/génétique , Différenciation cellulaire/génétique , Protéolyse , Modèles animaux de maladie humaine , Fibroblastes/métabolisme , Récepteurs Notch/métabolisme , Récepteurs Notch/génétique
18.
Poult Sci ; 103(7): 103794, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38718539

RÉSUMÉ

Avian feather color is a fascinating trait, and the genetic mechanism of duck plumage formation is still in the preliminary stage. In this study, feather color of Liancheng White ducks was analyzed by determination of melanin content and RNA-seq analysis. In this research, 9 ducks from Mallards (n = 3), Liancheng White (n = 3) and Pekin ducks (n = 3) were used by high performance liquid chromatography (HPLC) and Masson-Fontana staining to reveal the difference of feather melanin content. RNA-seq from 11 hair follicle tissues (1- and 8-wk-old) of Liancheng White ducks (n = 5) and Pekin ducks (n = 7) was used to analyze the candidate genes for the feather melanin synthesis, and Immunofluorescence experiment was used to show the protein expression in 6 black- and white-feathered ducks. Pectorale, skin, liver, fat, brain, heart, kidney, lung, spleen of an 8-wk-old black-feathered Mallard were collected for candidate gene expression. The results showed that the contents of feathers, beak, web melanin in Liancheng White ducks were higher than in Pekin ducks (p < 0.05). Melanin within hair follicles was located in the barb ridge and hair matrix of black feather duck, also we found that TYRP1, TYR, SOX10 genes were differentially expressed between Liancheng White and Pekin ducks (p < 0.05), and these genes were mainly expressed showed in duck skin tissues. This study revealed the unique feather color phenotype of Liancheng White duck shedding light on the transcriptome that underlies it.


Sujet(s)
Canards , Plumes , Analyse de profil d'expression de gènes , Follicule pileux , Pigmentation , Animaux , Plumes/composition chimique , Canards/génétique , Pigmentation/génétique , Follicule pileux/métabolisme , Analyse de profil d'expression de gènes/médecine vétérinaire , Transcriptome , Mélanines/métabolisme
19.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi ; 38(5): 626-632, 2024 May 15.
Article de Chinois | MEDLINE | ID: mdl-38752252

RÉSUMÉ

Objective: To summarize the dynamic and synchronized changes between the hair cycle and dermal adipose tissue as well as the impact of dermal adipose tissue on hair growth, and to provide a new research idea for the clinical treatment of hair loss. Methods: An extensive review of relevant literature both domestic and international was conducted, analyzing and summarizing the impact of dermal adipose precursor cells, mature dermal adipocytes, and the processes of adipogenesis in dermal adipose tissue on the transition of hair cycle phases. Results: Dermal adipose tissue is anatomically adjacent to hair follicles and closely related to the changes in the hair cycle. The proliferation and differentiation of dermal adipose precursor cells promote the transition of hair cycle from telogen to anagen, while mature adipocytes can accelerate the transition from anagen to catagen of the hair cycle by expressing signaling molecules, with adipogenesis in dermal adipose tissue and hair cycle transition signaling coexistence. Conclusion: Dermal adipose tissue affects the transition of the hair cycle and regulates hair growth by secreting various signaling molecules. However, the quantity and depth of existing literature are far from sufficient to fully elucidate its prominent role in regulating the hair cycle, and the specific regulatory mechanisms needs to be further studied.


Sujet(s)
Tissu adipeux , Différenciation cellulaire , Poils , Animaux , Humains , Adipocytes/cytologie , Adipocytes/métabolisme , Adipogenèse , Tissu adipeux/métabolisme , Tissu adipeux/cytologie , Alopécie/métabolisme , Prolifération cellulaire , Derme/métabolisme , Derme/cytologie , Poils/croissance et développement , Poils/métabolisme , Follicule pileux/métabolisme , Transduction du signal
20.
FEBS Open Bio ; 14(6): 955-967, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38711215

RÉSUMÉ

Patterned hair loss (PHL) or androgenetic alopecia is a condition affecting about 50% of people worldwide. Several pharmacological medications have been developed over the years, but few studies have investigated their effectiveness. Therefore, new, safer and more effective strategies are required. Recent investigations showed that Annurca apple extract application could induce keratin production and promote hair growth thanks to the high amount of procyanidin B2 contained in. Hence, this study aimed to investigate the role of an Annurca apple extract in preventing PHL by testing it on human follicle dermal papilla cells (HFDPCs) for the first time. Treatment of HFDPCs with Annurca apple extract counteracted intracellular reactive oxygen species accumulation by increasing the activity of antioxidant enzymes such as superoxide dismutase 2 and catalase. Furthermore, treatment with Annurca apple extract increased ß-catenin and fibroblast growth factor 2, which are involved in hair growth stimulation. These data suggest that Annurca apple extract may be a potential therapeutically useful nutraceutical product for preventing or treating hair loss by reducing oxidative stress and inducing the expression of hair growth-related factors.


Sujet(s)
Alopécie , Malus , Stress oxydatif , Extraits de plantes , Espèces réactives de l'oxygène , Stress oxydatif/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Alopécie/traitement médicamenteux , Alopécie/métabolisme , Humains , Malus/composition chimique , Espèces réactives de l'oxygène/métabolisme , Antioxydants/pharmacologie , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/métabolisme , Proanthocyanidines/pharmacologie , Catéchine/pharmacologie , Superoxide dismutase/métabolisme , Cellules cultivées , Biflavonoïdes/pharmacologie , Catalase/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...